Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra clinical trials

Explore recruiting diffuse cutaneous systemic sclerosis dcssc difficult to treat rheumatoid arthritis d2tra clinical trials.

Recruiting diffuse cutaneous systemic sclerosis dcssc difficult to treat rheumatoid arthritis d2tra studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A single-arm, open-label, multi-centre, phase I/II first-in-human study evaluating the safety and clinical activity of QEL-005, an autologous CAR T-regulatory cell therapy treatment targeting CD19, in patients with diffuse cutaneous systemic sclerosis (dcSSc) and in patients with difficult to treat rheumatoid arthritis (D2TRA).

Spain, Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra trials by city

Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Toronto Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Vancouver Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Montreal Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Calgary Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Edmonton Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Ottawa Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Winnipeg Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Quebec City Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Hamilton Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Kitchener Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in London Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Halifax Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in New York Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Los Angeles Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Chicago Diffuse Cutaneous Systemic Sclerosis Dcssc Difficult To Treat Rheumatoid Arthritis D2tra in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease